Lidozone Ear Drop is a topical pharmaceutical formulation containing Lidocaine 1% w/v and Phenazone 4% w/v, designed for the symptomatic relief of ear pain and inflammation. Lidocaine, a local anesthetic, acts by blocking sodium ion channels in neuronal membranes, thereby inhibiting nerve impulse conduction and providing effective analgesia. Phenazone, an analgesic and anti-inflammatory agent, contributes to pain relief and reduces inflammation through its non-steroidal mechanism, enhancing patient comfort. This combination is particularly useful in managing otalgia associated with otitis externa, minor ear infections, or trauma. Lidozone Ear Drop is intended for local application into the external auditory canal, ensuring rapid onset of action and targeted therapeutic effect. It should be used as directed by a healthcare professional, with caution in patients with known hypersensitivity to local anesthetics or phenazone derivatives. The formulation is contraindicated in cases of tympanic membrane perforation or middle ear infections unless specifically advised by a physician. Adverse effects are uncommon but may include local irritation or allergic reactions. Lidozone Ear Drop offers an effective, dual-action approach to ear pain management, combining anesthetic and anti-inflammatory properties to improve patient comfort and facilitate recovery.